Abstract
From the *Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY the †Children’s Hospital of Los Angeles, Keck School of Medicine, USC, Los Angeles, CA. Received May 24, 2022; accepted June 30, 2022. R.J.M. reports the following conflicts of interest: Former Medical Director for Abbott Laboratories and Nestle Nutrition; Retiree, Abbott Laboratories; Stockholder, Abbott Laboratories. He lists Site PI for Takeda for short bowel and teduglutide registries. R.D.B. reports no conflicts of interest. Sources of Funding: Scientific Advisory Board for Gesea Biosciences. Address correspondence and reprint requests to Robert D. Baker, MD, PhD, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, South Campus, Sherman Hall, Rm 111, Buffalo, NY 14222 (e-mail: [email protected]).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of pediatric gastroenterology and nutrition
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
